MOESM1 of PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma

Additional file 1: Table S1. The high sensitivity, specificity and AUC values of PFN2 in ESCC, HGIN, and LGIN.